Log in to post a reply
Dec 30, 2019 07:20PM
My original tumor in 1999 was considered ER+/PR+, but ER was only 5% while PR was 95%. Many recent studies have shown that breast cancer tumors where ER receptors are less than 10% act more like ER- tumors. I was stage 1B then, and had a lumpectomy, ALND, radiation, and Tamoxifen.
My current tumor is highly ER+ (95%) and PR+ (69%), HER2-. I had BMX, chemo, and am currently on Zoladex and Tamoxifen, but will switch to an AI once they get me into menopause.
First Dx at 27 years old in 1999, 2nd Dx 2018, 3rd Dx 2019... Current Oncotype: 26
12/7/1999, IDC, Left, 1cm, Stage IB, Grade 2, 0/14 nodes, ER+/PR+
12/22/1999 Lumpectomy: Left; Lymph node removal: Left, Sentinel, Underarm/Axillary
1/31/2000 Whole-breast: Breast, Lymph nodes
2/1/2000 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone)
8/24/2016 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone)
9/5/2018 Lumpectomy: Left
9/7/2018, DCIS, Left, <1cm, Stage 0, Grade 1
5/31/2019, IDC, Left, 3cm, Stage IIA, Grade 3, 0/2 nodes, ER+/PR+, HER2- (IHC)
8/5/2019 Lymph node removal: Left; Mastectomy: Left; Prophylactic mastectomy: Right; Reconstruction (left): Latissimus dorsi flap, Tissue expander placement; Reconstruction (right): Tissue expander placement
9/4/2019 Cytoxan (cyclophosphamide), Taxotere (docetaxel)
12/2/2019 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone), Zoladex (goserelin)